Status:
COMPLETED
Atorvastatin vs Colchicine in Decrease of Troponin I of High Sensitivity in Patients With Rheumatoid Arthritis.
Lead Sponsor:
Hospital Central "Dr. Ignacio Morones Prieto"
Conditions:
Cardiovascular Diseases
Arthritis, Rheumatoid
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Pilot study. The primary end point is the evaluation the efficacy of treatment with atorvastatin compared to colchicine for the decrease of high sensitivity troponin I levels in patients with rheumato...
Detailed Description
A pilot study will be conducted in patients older than 18 years with a diagnosis of rheumatoid arthritis in the Hospital Central "Dr. Ignacio Morones Prieto", these patients will be evaluated by the r...
Eligibility Criteria
Inclusion
- Patients older than 18 years with a diagnosis of rheumatoid arthritis according to the diagnoses of the American College of Rheumatology and the European League against rheumatism 2010 with severe disease activity according to DAS 28\> 5.1.
- Patients who are accepted according to previous criteria and with signed informed consent.
Exclusion
- Patients with a history of ischemic heart disease.
- Patients with a history of heart failure with decreased left ventricular ejection fraction
- Patients with chronic kidney disease.
Key Trial Info
Start Date :
August 14 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2019
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04056039
Start Date
August 14 2018
End Date
June 30 2019
Last Update
August 14 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Central "Dr Ignacio Morones Prieto"
San Luis Potosí City, Mexico, 78290